These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37236658)

  • 21. Association of the US President's Emergency Plan for AIDS Relief's Funding With Prevention of Mother-to-Child Transmission of HIV in Kenya.
    Barnhart DA; Tsikhutsu I; Kirui D; Sawe F; Muli J; Sugut W; Abboud N; Birx D; Hamm T; Coakley P; Hickey PW; Wolfman V; Lee E; Spiegelman D
    JAMA Netw Open; 2019 Sep; 2(9):e1911318. PubMed ID: 31517966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policy analysis of the Global Financing Facility in Uganda.
    Wanduru P; Kwesiga D; Kinney M; George A; Waiswa P
    Glob Health Action; 2024 Dec; 17(1):2336310. PubMed ID: 38979635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of PEPFAR transition on HIV service delivery at health facilities in Uganda.
    Wilhelm JA; Qiu M; Paina L; Colantuoni E; Mukuru M; Ssengooba F; Bennett S
    PLoS One; 2019; 14(10):e0223426. PubMed ID: 31596884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research's Implementation of the U.S. President's Emergency Plan for AIDS Relief.
    Lee EH; Ganesan K; Khamadi SA; Meribe SC; Njeru D; Adamu Y; Magala F; Crowell TA; Akom E; Agaba P; Desai P; Hamm T; Teyhen D; Ake JA; Polyak CS; Shaffer D; Sawe F; Hickey PW
    Am J Trop Med Hyg; 2021 Jan; 104(1):12-25. PubMed ID: 33241783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghana's HIV epidemic and PEPFAR's contribution towards epidemic control.
    Ali H; Amoyaw F; Baden D; Durand L; Bronson M; Kim A; Grant-Greene Y; Imtiaz R; Swaminathan M
    Ghana Med J; 2019 Mar; 53(1):59-62. PubMed ID: 31138945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond indicators: advances in global HIV monitoring and evaluation during the PEPFAR era.
    Porter LE; Bouey PD; Curtis S; Hochgesang M; Idele P; Jefferson B; Lemma W; Myrick R; Nuwagaba-Biribonwoha H; Prybylski D; Souteyrand Y; Tulli T
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S120-6. PubMed ID: 22797733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR).
    Leeper SC; Reddi A
    AIDS; 2010 Sep; 24(14):2145-9. PubMed ID: 20606571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.
    Chun HM; Dirlikov E; Cox MH; Sherlock MW; Obeng-Aduasare Y; Sato K; Voetsch AC; Ater AD; Romano ER; Tomlinson H; Modi S; Achrekar A; Nkengasong J;
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):317-324. PubMed ID: 36952290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14.
    Moucheraud C; Sparkes S; Nakamura Y; Gage A; Atun R; Bossert TJ
    Health Aff (Millwood); 2016 May; 35(5):847-55. PubMed ID: 27140991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.
    Goosby E; Dybul M; Fauci AS; Fu J; Walsh T; Needle R; Bouey P
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S51-6. PubMed ID: 22797740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief.
    Chi BH; Adler MR; Bolu O; Mbori-Ngacha D; Ekouevi DK; Gieselman A; Chipato T; Luo C; Phelps BR; McClure C; Mofenson LM; Stringer JS
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(Suppl 3):S78-87. PubMed ID: 22797744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: stakeholder perspectives.
    Sharma A; Chiliade P; Michael Reyes E; Thomas KK; Collens SR; Rafael Morales J
    Glob Health Action; 2013 Dec; 6():22571. PubMed ID: 24331715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths - Uganda, 2004-2022.
    Dirlikov E; Kamoga J; Talisuna SA; Namusobya J; Kasozi DE; Akao J; Birabwa E; Ward JA; Elur B; Shiraishi RW; Corcoran C; Vasireddy V; Nelson R; Nelson LJ; Borgman M; Magongo EN; Kisaakye LN; Katureebe C; Kirungi W; Musinguzi J;
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):90-94. PubMed ID: 36701255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From emergency to sustainability: shifting objectives in the US Government's HIV response in Tanzania.
    Marten MG
    Glob Public Health; 2017 Aug; 12(8):988-1003. PubMed ID: 26609563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV development assistance and adult mortality in Africa.
    Bendavid E; Holmes CB; Bhattacharya J; Miller G
    JAMA; 2012 May; 307(19):2060-7. PubMed ID: 22665105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary medical male circumcision for HIV prevention among adolescents in Kenya: Unintended consequences of pursuing service-delivery targets.
    Gilbertson A; Ongili B; Odongo FS; Hallfors DD; Rennie S; Kwaro D; Luseno WK
    PLoS One; 2019; 14(11):e0224548. PubMed ID: 31682626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEPFAR, health system strengthening, and promoting sustainability and country ownership.
    Palen J; El-Sadr W; Phoya A; Imtiaz R; Einterz R; Quain E; Blandford J; Bouey P; Lion A
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S113-9. PubMed ID: 22797732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investing in HIV services while building Kenya's health system: PEPFAR's support to prevent mother-to-child HIV transmission.
    Dutta A; Wallace N; Savosnick P; Adungosi J; Kioko UM; Stewart S; Hijazi M; Gichanga B
    Health Aff (Millwood); 2012 Jul; 31(7):1498-507. PubMed ID: 22778339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.